IP Library Granted Patent US 8,865,642
Granted Patent B2
US 8,865,642 · App. 13/635,095 · Granted Oct 21, 2014

Natural plant products for control of cancer metastasis

Inventors: Amy Fulton (Baltimore, MD); Namita Kundu (Columbia, MD)
Assignee: University of Maryland, Baltimore
A61K36/888A61K38/168A61K38/56
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,865,642
App. No.
13/635,095
Granted
Oct 21, 2014
Kind
B2
Abstract

The invention provides compositions comprising soluble extracts or isolated polypeptides from the edible roots of the plant Colocasia , such as Colocasia esculenta , commonly known as Taro, and from Xanthosoma , such as Xanthosoma sagittifolium, commonly known as Malanga Blanca or Yautia. The compositions exhibit inhibitory effects on metastasis of cancer cells in particular breast and prostate cancer cells and have therapeutic pharmacological activity, Pharmaceutical compositions for the treatment of cancer by inhibiting metastasis which comprises an effective amount of the described extract or isolated polypeptide thereof and optionally a pharmaceutical acceptable carrier are described.

Claims (4)

1. A method of treating breast cancer by inhibiting metastasis in a subject in need thereof, comprising administering to the subject a composition comprising a therapeutically effective amount of an isolated polypeptide from Taro ( Colocasia esculenta ), wherein the isolated polypeptide comprises SEQ ID NO:1 and SEQ ID NO:2, wherein the isolated polypeptide has an approximate molecular weight of 30 KD based on size exclusion chromatography.

2. The method of claim 1 , wherein the isolated polypeptide is administered with a carrier molecule.

3. The method of claim 1 , wherein the subject is a human.

4. The method of claim 1 , wherein the composition is administered parenterally.

Assignments (3)
CONFIRMATORY LICENSE Recorded Dec 31, 2014
From: THE UNIVERSITY OF MARYLAND, BALTIMORE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 034605/0188 →
CONFIRMATORY LICENSE Recorded Oct 16, 2012
From: THE UNIVERSITY OF MARYLAND, BALTIMORE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029137/0978 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2012
From: FULTON, AMY; KUNDU, NAMITA
To: UNIVERSITY OF MARYLAND, BALTIMORE
Reel/Frame 029017/0100 →
Continuity (2)
Provisional Application 61314210 · Mar 16, 2010
Related Publication 20130017225A1 · Jan 17, 2013